Suvretta Capital Management’s Kezar Life Sciences KZR Stock Holding History

Suvretta Capital Management’s Portfolio KZR Stock Details KZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.32M	Hold	716,759	–	–	0.14%	59
2025 Q4	$4.51M	Hold	716,759	–	–	0.09%	69
2025 Q3	$2.8M	Hold	716,759	–	–	0.07%	72
2025 Q2	$3.28M	Hold	716,759	–	–	0.1%	68
2025 Q1	$3.5M	Hold	716,759	–	–	0.13%	68
2024 Q4	$4.82M	Hold	716,759	–	–	0.16%	65
2024 Q3	$5.54M	Hold	716,759	–	–	0.18%	62
2024 Q2	$4.3M	Hold	716,759	–	–	0.16%	56
2024 Q1	$6.46M	Hold	716,759	–	–	0.24%	60
2023 Q4	$6.79M	Hold	716,759	–	–	0.31%	50
2023 Q3	$8.53M	Hold	716,759	–	–	0.46%	47
2023 Q2	$17.6M	Buy	716,759 +28,000	+4%	+$729K	0.94%	40
2023 Q1	$21.6M	Buy	688,759 +338,333	+97%	+$19.6M	0.91%	37
2022 Q4	$24.7M	Buy	350,426 +22,874	+7%	+$1.7M	1.04%	35
2022 Q3	$28.2M	Sell	327,552 -113,678	-26%	-$11M	1.17%	33
2022 Q2	$36.5M	Buy	441,230 +300,234	+213%	+$26.5M	1.39%	30
2022 Q1	$23.4M	Hold	140,996	–	–	0.72%	45
2021 Q4	$23.6M	Hold	140,996	–	–	0.46%	46
2021 Q3	$12.2M	Hold	140,996	–	–	0.21%	58
2021 Q2	$7.66M	Hold	140,996	–	–	0.11%	84
2021 Q1	$8.4M	Hold	140,996	–	–	0.12%	78
2020 Q4	$7.36M	Buy	140,996 +85,406	+154%	+$4.75M	0.11%	69
2020 Q3	$2.69M	Hold	55,590	–	–	0.05%	76
2020 Q2	$2.88M	Buy	55,590 +46,600	+518%	+$2.35M	0.06%	64
2020 Q1	$392K	Buy	+8,990	New	+$366K	0.01%	64

Other funds holding KZR

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Rangeley Capital New Canaan, Connecticut $103M AUM 77.36% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PLC

Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Suvretta Capital Management's KZR Position: Q1 2026 in Review

Suvretta Capital Management held its Kezar Life Sciences (KZR) position steady in Q1 2026 at 716,759 shares worth $5.32M. The position accounts for 0.14% of the portfolio, ranked #59.

Suvretta Capital Management first reported a position in KZR in Q1 2020 and has held it in 25 quarters since. The position peaked at $36.5M in Q2 2022. 43 funds tracked by Wall St. Rank hold KZR as of Q1 2026.

Suvretta Capital Management held 716,759 shares of Kezar Life Sciences worth $5.32M as of Q1 2026.
Suvretta Capital Management left its Kezar Life Sciences share count unchanged in Q1 2026.
Kezar Life Sciences made up 0.14% of Suvretta Capital Management's portfolio in Q1 2026, its #59 holding.
Suvretta Capital Management first reported a position in Kezar Life Sciences in Q1 2020 and has held it in 25 quarters since.
Suvretta Capital Management's Kezar Life Sciences position peaked at $36.5M in Q2 2022.
43 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q1 2026.

Based on Suvretta Capital Management's 13F filing for Q1 2026, filed 15 May 2026.